| Cancer neoantigens: challenges and future directions for prediction, prioritization, and validation ES Borden, KH Buetow, MA Wilson, KT Hastings Frontiers in oncology 12, 836821, 2022 | 35 | 2022 |
| Shared gene expression and immune pathway changes associated with progression from nevi to melanoma ES Borden, AC Adams, KH Buetow, MA Wilson, JE Bauman, ... Cancers 14 (1), 3, 2021 | 12 | 2021 |
| Neoantigen fitness model predicts lower immune recognition of cutaneous squamous cell carcinomas than actinic keratoses ES Borden, P Kang, HM Natri, TN Phung, MA Wilson, KH Buetow, ... Frontiers in Immunology 10, 488926, 2019 | 11 | 2019 |
| Origin of many-body vibrational frequency shifts in water clusters JP Heindel, ES Knodel, DP Schofield The Journal of Physical Chemistry A 122 (33), 6724-6735, 2018 | 8 | 2018 |
| NeoScore integrates characteristics of the neoantigen: MHC class I interaction and expression to accurately prioritize immunogenic neoantigens ES Borden, S Ghafoor, KH Buetow, BJ LaFleur, MA Wilson, KT Hastings The Journal of Immunology 208 (7), 1813-1827, 2022 | 7 | 2022 |
| Targeted therapy and traditional chemotherapy in melanoma and cutaneous squamous cell carcinoma VT Ma, CT Haring, G Warrier, PL Swiecicki Facial Plastic Surgery 36 (02), 186-193, 2020 | 6 | 2020 |
| High GILT Expression Is Associated with Improved Survival in Metastatic Melanoma Patients Treated with Immune Checkpoint Inhibition AC Adams, ES Borden, AM Macy, N Thomson, H Cui, MI Gimbel, ... Cancers 14 (9), 2200, 2022 | 1 | 2022 |
| Distinct sets of molecular characteristics define tumor-rejecting neoantigens AC Adams, AM Macy, ES Borden, LM Herrmann, CA Brambley, T Ma, X Li, ... bioRxiv, 2024.02. 13.579546, 2024 | | 2024 |
| 136 Neoantigen-specific CD8 T cell responses constrain cutaneous squamous cell carcinoma AC Adams, AM Macy, ES Borden, LM Herrmann, KH Buetow, MA Wilson, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| 137 Majority of mutations in cutaneous squamous cell carcinoma are unique to individual tumors ES Borden, AC Adams, AM Macy, TY Juan, DJ Roe, KH Buetow, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| 084 Neoantigen-specific T cell responses constrain cutaneous squamous cell carcinoma AC Adams, AM Macy, ES Borden, LM Herrmann, KH Buetow, MA Wilson, ... Journal of Investigative Dermatology 143 (5), S14, 2023 | | 2023 |
| Abstract A001: Shared gene expression and immune pathway changes associated with progression from nevi to melanoma ES Borden, AC Adams, KH Buetow, MA Wilson, JE Bauman, ... Cancer Prevention Research 15 (12_Supplement_2), A001-A001, 2022 | | 2022 |
| Abstract A006: Shared gene expression and immune pathway changes associated with progression from nevi to melanoma ES Borden, AC Adams, KH Buetow, MA Wilson, JE Bauman, ... Cancer Prevention Research 15 (12_Supplement_2), A006-A006, 2022 | | 2022 |
| 005 Novel cutaneous squamous cell carcinoma cell lines constrained by T cell-mediated immune responses AC Adams, ES Borden, AM Macy, KH Buetow, MA Wilson, DJ Roe, ... Journal of Investigative Dermatology 142 (8), S1, 2022 | | 2022 |
| Penalized regression analysis identifies features of the peptide: MHC class I interaction and mRNA expression as key to prioritizing neoantigen immunogenicity ES Borden, TN Phung, KH Buetow, B Lafleur, MA Wilson, KT Hastings The Journal of Immunology 206 (1_Supplement), 104.08-104.08, 2021 | | 2021 |
Kenneth BuetowArizona State UniversityVerified email at asu.edu
